Damora Therapeutics is trading higher at $27.71, up +5.48%, despite no identified company-specific catalyst.
- Its investor-relations page lists no announcement dated September 9 or September 10; its latest release was a routine September 3 inducement-grant announcement.
- Broader markets are lower following hotter producer-inflation data, so the positive move appears unrelated to today’s macro direction. No clear catalyst has been confirmed.